• The Endpoint Podcast. Episode 29: With Scott Schliebner, VP and Global Head of Drug Development Consulting, Novotech

  • May 15 2024
  • Length: 43 mins
  • Podcast

The Endpoint Podcast. Episode 29: With Scott Schliebner, VP and Global Head of Drug Development Consulting, Novotech By cover art

The Endpoint Podcast. Episode 29: With Scott Schliebner, VP and Global Head of Drug Development Consulting, Novotech

Listen for free

View show details

  • Summary

  • Scott join Liam on this week’s podcast episode. Scott is VP and Global Head of Drug Development at Novotech. Founded in 1997, Novotech is a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase. In todays session we explore Scott’s origin story, discuss it means to him to put patients first, dive into ways we can deliver trials differently and some of his biggest lessons learned over the years in the clinical trial space and much more!
    Show more Show less
activate_primeday_promo_in_buybox_DT
Physical Illness & Disease Hygiene & Healthy Living
Show more Show less

What listeners say about The Endpoint Podcast. Episode 29: With Scott Schliebner, VP and Global Head of Drug Development Consulting, Novotech

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available